Google Inc. (NASDAQ:GOOGL) began issuing the Android 4.4.3 KitKat update on Monday to the company’s Nexus line of devices. Android 4.4.3 is also coming this week to Google Play edition smartphones sold through the company’s online store. Since Motorola released the Moto X in 2013, the company has issued updates to its Moto smartphone line days after they are released by Google – in stark contrast to the longer delay experienced by Samsung and HTC customers. Motorola credits its quick turnaround time to the version of Android it uses, which is a relatively unmodified or “stock” version of the mobile operating system. Google Inc (NASDAQ:GOOGL) net profit margin is 21.30% and weekly performance is -2.93%. On last trading day company shares ended up $553.76. Analysts mean target price for the company is $660.88. Google Inc (NASDAQ:GOOGL) distance from 50-day simple moving average (SMA50) is 1.05%.
MELA Sciences, Inc (NASDAQ:MELA) announced that it has initiated a study to examine the real-world clinical impact of MelaFind on dermatologists’ decision to biopsy pigmented skin lesions that are suspicious for melanoma. Darrell Rigel, MD, MS, Clinical Professor of Dermatology at New York University Langone Medical Center, will be the Principle Investigator for the study. MELA Sciences Inc (NASDAQ:MELA) shares fell -5.51% in last trading session and ended the day on $0.355. Its return on assets is -153.90%. MELA Sciences Inc (NASDAQ:MELA) quarterly performance is -50.70%.
On May 13, 2014 Transcept Pharmaceuticals, Inc. (NASDAQ:TSPT) announced financial results for the three months ended March 31, 2014. For the quarter ended March 31, 2014 and 2013, Transcept recorded $0.4 million and $0.5 million, respectively, of royalty revenue on Intermezzo net sales generated by Purdue. The 2013 royalty revenue was offset by $6.3 million related to a contribution by Transcept in December 2012 to an Intermezzo direct-to-consumer (DTC) advertising campaign led by Purdue. Transcept Pharmaceuticals Inc (NASDAQ:TSPT) shares moved up 10.16% in last trading session and was closed at $2.06, while trading in range of $1.85 – $2.18. Transcept Pharmaceuticals Inc (NASDAQ:TSPT) year to date (YTD) performance is 5.10%.
On May 6, Oxford Resource Partners, LP (NYSE:OXF) announced first quarter 2014 financial results. Net loss was $10.6 million for the first quarter of 2014 compared to a net loss of $6.3 million for the first quarter of 2013. There was $3.9 million of additional interest expense attributable to the new credit facilities for the first quarter of 2014 over the first quarter of 2013. Adjusted Net Loss2 was $9.9 million for the first quarter of 2014, when excluding a $0.4 million loss relating to the change in fair value of warrants, $0.2 million of losses on disposal of assets and $0.1 million of restructuring expenses, and without any adjustment for the additional interest expense. Oxford Resource Partners, LP (NYSE:OXF) ended the last trading day at $0.800. Company weekly volatility is calculated as 9.19% and price to cash ratio as 5.41. Oxford Resource Partners, LP (NYSE:OXF) showed a negative weekly performance of -25.23%.
LIQUEFIED NATURAL GS (OTCMKTS:LNGLF) On last trading day company shares ended up $1.37.